Merit Financial Group, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1621225
ALPHARETTA, GA
Position in BCRX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$191,850
+$91,650 QoQ
Shares Held
19,185
+43.6% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#209
of 316 holders
Holding Since
Mar 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $14,160,724 across 17 Drug Manufacturers - Specialty & Generic names. BCRX ranks #11 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
9,856 | $5,340,273 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,744 | $3,159,110 | |
| 3 | VTRS |
Viatris Inc
|
74,483 | $1,182,785 | |
| 4 | ZTS |
Zoetis Inc.
|
13,254 | $952,428 | |
| 5 | HLN |
Haleon plc
|
101,892 | $950,650 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
35,173 | $563,820 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
4,251 | $471,603 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
5,474 | $350,060 |
All Filings in BCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $191,850 | 19,185 | Shares | Other | 2026-07-20 | |
| 2025-03-31 | $100,200 | 13,360 | Shares | Sole | 2025-04-09 | |
| No filing history on record for this holder in this stock. | ||||||